Mario C.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
Data & Insights
Has run more than one trial at 387 of 682 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating various forms of breast cancer, with particular emphasis on hormone receptor-positive (HR+) and HER2-negative variants.
- Advanced/Metastatic Disease Management
- Endocrine Therapy Resistance
- Early-Stage Treatment Approaches
Focused on developing therapeutic strategies for patients with high risk of relapse and hormone-sensitive disease.
Novel Therapeutic Approaches
Active in evaluating innovative treatment combinations involving targeted therapies and immunotherapeutic agents.
- CDK4/6 Inhibitor Combinations
- PI3K/AKT Pathway Targeting
- Radioligand Therapies
Investigates treatment solutions for hormone receptor-positive breast cancer patients who have progressed on standard therapies.
Advanced Solid Tumors
Conducts research on advanced solid malignancies with a focus on molecular targeting and biomarker-driven approaches.
- Molecular Pathway Inhibition
- Biomarker Analysis
- First-in-Human Studies
Evaluates novel compounds for patients with specific genetic alterations and treatment-resistant cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.